These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 11435602)
41. Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor. Goueli BS; Janknecht R Oncogene; 2003 Sep; 22(39):8042-7. PubMed ID: 12970752 [TBL] [Abstract][Full Text] [Related]
42. The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes. Bedard KM; Underbrink MP; Howie HL; Galloway DA J Virol; 2008 Apr; 82(8):3894-902. PubMed ID: 18256157 [TBL] [Abstract][Full Text] [Related]
43. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells. Chang JT; Yang HT; Wang TC; Cheng AJ Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690 [TBL] [Abstract][Full Text] [Related]
44. Keratinocyte growth conditions modulate telomerase expression, senescence, and immortalization by human papillomavirus type 16 E6 and E7 oncogenes. Fu B; Quintero J; Baker CC Cancer Res; 2003 Nov; 63(22):7815-24. PubMed ID: 14633708 [TBL] [Abstract][Full Text] [Related]
45. Transactivation of prothymosin alpha and c-myc promoters by human papillomavirus type 16 E6 protein. Kinoshita T; Shirasawa H; Shino Y; Moriya H; Desbarats L; Eilers M; Simizu B Virology; 1997 May; 232(1):53-61. PubMed ID: 9185588 [TBL] [Abstract][Full Text] [Related]
46. GRIM-19 Restores Cervical Cancer Cell Senescence by Repressing hTERT Transcription. Zhou Y; Xu F; Tao F; Feng D; Ling B; Qian L; Yang X; Wang Q; Wang H; Zhao W; Cheng Y; Shan G; Kalvakolanu DV; Xiao W J Interferon Cytokine Res; 2016 Aug; 36(8):506-15. PubMed ID: 27142689 [TBL] [Abstract][Full Text] [Related]
47. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Greenberg RA; O'Hagan RC; Deng H; Xiao Q; Hann SR; Adams RR; Lichtsteiner S; Chin L; Morin GB; DePinho RA Oncogene; 1999 Feb; 18(5):1219-26. PubMed ID: 10022128 [TBL] [Abstract][Full Text] [Related]
48. Requirement of E7 oncoprotein for viability of HeLa cells. Nishimura A; Nakahara T; Ueno T; Sasaki K; Yoshida S; Kyo S; Howley PM; Sakai H Microbes Infect; 2006 Apr; 8(4):984-93. PubMed ID: 16500131 [TBL] [Abstract][Full Text] [Related]
49. Identification of Mad as a repressor of the human telomerase (hTERT) gene. Oh S; Song YH; Yim J; Kim TK Oncogene; 2000 Mar; 19(11):1485-90. PubMed ID: 10723141 [TBL] [Abstract][Full Text] [Related]
50. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells. Jagadeesh S; Kyo S; Banerjee PP Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011 [TBL] [Abstract][Full Text] [Related]
51. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Dimri GP; Martinez JL; Jacobs JJ; Keblusek P; Itahana K; Van Lohuizen M; Campisi J; Wazer DE; Band V Cancer Res; 2002 Aug; 62(16):4736-45. PubMed ID: 12183433 [TBL] [Abstract][Full Text] [Related]
52. Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6. Duffy CL; Phillips SL; Klingelhutz AJ Virology; 2003 Sep; 314(1):196-205. PubMed ID: 14517073 [TBL] [Abstract][Full Text] [Related]
53. E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells. Al Moustafa AE; Foulkes WD; Benlimame N; Wong A; Yen L; Bergeron J; Batist G; Alpert L; Alaoui-Jamali MA Oncogene; 2004 Jan; 23(2):350-8. PubMed ID: 14724563 [TBL] [Abstract][Full Text] [Related]
54. Divergent expression changes of telomerase and E6/E7 mRNA, following integration of human papillomavirus type 33 in cultured epithelial cells. Peitsaro P; Ruutu M; Syrjänen S; Johansson B Scand J Infect Dis; 2004; 36(4):302-4. PubMed ID: 15198189 [TBL] [Abstract][Full Text] [Related]
55. Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repression. Horikawa I; Cable PL; Mazur SJ; Appella E; Afshari CA; Barrett JC Mol Biol Cell; 2002 Aug; 13(8):2585-97. PubMed ID: 12181331 [TBL] [Abstract][Full Text] [Related]
56. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Takakura M; Kyo S; Kanaya T; Hirano H; Takeda J; Yutsudo M; Inoue M Cancer Res; 1999 Feb; 59(3):551-7. PubMed ID: 9973199 [TBL] [Abstract][Full Text] [Related]
57. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent. Tomaić V; Pim D; Banks L Virology; 2009 Oct; 393(1):7-10. PubMed ID: 19700180 [TBL] [Abstract][Full Text] [Related]
58. BRCA1 interaction with human papillomavirus oncoproteins. Zhang Y; Fan S; Meng Q; Ma Y; Katiyar P; Schlegel R; Rosen EM J Biol Chem; 2005 Sep; 280(39):33165-77. PubMed ID: 15983032 [TBL] [Abstract][Full Text] [Related]
59. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737 [TBL] [Abstract][Full Text] [Related]
60. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation. Liu Y; McKalip A; Herman B J Cell Biochem; 2000 May; 78(2):334-49. PubMed ID: 10842327 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]